2DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus.Ann Intern Med,1999,131 (4) :281-303.
3Melander A. Review of previous impaired glucose tolerance intervention studies. Diabetes Med, 1996,13 ( 3 Suppl 2 ): S20-S22.
4Matsu moto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care, 1997,20 (10): 1562 -1568.
5Belfiore F, lannelo S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA level.Mol Genet Metab, 1998 ,63 (2): 134-141.
6Gregorio F, Ambrosi F, Manfrini S, et al. Metformin, plasma glucose and free fatty acides in type 2 diabetic out-patients: results of a clinical study. Diabetes Res Clin Pract,1997,37( 1 ) :21-33.
7Knowler WC, Barrett-Connor E, Fowler SE, et al. The Diabetes Prevention Program (DDP): reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med ,2002,346(6) :393-403.
8E. Corpeleijn,E. J. M. Feskens,E. H. J. M. Jansen,M. Mensink,W. H. M. Saris,T. W. A. Bruin,E. E. Blaak.Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study[J]Diabetologia,2006(10).
9ADA.Standards of Medical Care in Diabetes-2010Diabetes Care,2010.
10Li GW,Zhang P,Wang J X,et al.T he long-ter m effectof lifestyle interventions to prevent diabetes in the ChinaDa Qing Diabetes Prevention Study:a 20-year follow-upstudyThe Lancet,2008.
